Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04528498 · ClinicalTrials.gov registry record
Embryo Health Study
A clinical trial of Infertility and Hereditary Diseases, sponsored by Genomic Prediction.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04528498: Recruiting study of Infertility and Hereditary Diseases, sponsored by Genomic Prediction.
NCT04528498 is a study of Infertility and Hereditary Diseases that is actively recruiting participants, run by Genomic Prediction. The registered enrollment target is 500 participants, below the 7,583-participant average among 74 other Infertility trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04528498, a study of Infertility and Hereditary Diseases, is actively recruiting participants, sponsored by Genomic Prediction.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and genetic testing on their embryos for aneuploidies will be given the option to obtain information of their embryos' polygenic disease risk after receiving genetic counseling.
Conditions Studied
Interventions
- OTHER Preimplantation Genetic Testing
Study Locations (1)
New Jersey
- Genomic Prediction Clinical Laboratory - North Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2025-12-01 |
What NCT04528498 shows while recruiting
NCT04528498 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 7,583-participant average among 74 other Infertility trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which Preimplantation Genetic Testing is the first listed.
NCT04528498 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT04528498 about?
NCT04528498 is a clinical study titled "Embryo Health Study". This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and genetic testing on their embryos for aneuploidies will be given the option to obtain information of the...
What is the current status of trial NCT04528498?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2020-12-01. Estimated completion is 2025-12-01.
What conditions does trial NCT04528498 study?
This clinical trial studies the following conditions: Infertility, Hereditary Diseases.
What interventions are being tested in trial NCT04528498?
The interventions under investigation include: Preimplantation Genetic Testing (OTHER).
Who is sponsoring clinical trial NCT04528498?
This trial is sponsored by Genomic Prediction, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04528498 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04528498's enrollment target sits among peer trials
500 24th of 74 higher than 50 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
RECRUITING · Phase 1
-
Non-Euploid Embryo Transfer (NEET) Registry
RECRUITING
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Apple Women's Health Study
RECRUITING
-
Discarded Materials Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI